This secretion of interferon-gamma (IFN-γ) can prompt cancer cells to increase the expression levels of Major Histocompatibility Complex-I (MHC-I) and CD86.Ultimately, this upregulated expression of MHC-I and CD86 can enhance T-cell-mediated anti-tumor immune responses (47). This evidence concerns the gene IFNG and neoplasm.